Boyd L. Harrison

2.5k total citations
46 papers, 1.4k citations indexed

About

Boyd L. Harrison is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Boyd L. Harrison has authored 46 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 20 papers in Cellular and Molecular Neuroscience and 17 papers in Organic Chemistry. Recurrent topics in Boyd L. Harrison's work include Neuroscience and Neuropharmacology Research (17 papers), Receptor Mechanisms and Signaling (14 papers) and Pharmacological Receptor Mechanisms and Effects (8 papers). Boyd L. Harrison is often cited by papers focused on Neuroscience and Neuropharmacology Research (17 papers), Receptor Mechanisms and Signaling (14 papers) and Pharmacological Receptor Mechanisms and Effects (8 papers). Boyd L. Harrison collaborates with scholars based in United States, Canada and China. Boyd L. Harrison's co-authors include Bruce M. Baron, Lee E. Schechter, Francesco G. Salituro, Michael G. Palfreyman, John H. Kehne, Sharon Rosenzweig‐Lipson, Gary Stack, Annmarie L. Sabb, Deborah L. Smith and Timothy C. McCloskey and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Brain Research.

In The Last Decade

Boyd L. Harrison

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boyd L. Harrison United States 23 661 642 486 213 88 46 1.4k
Michael Bös Switzerland 21 890 1.3× 858 1.3× 536 1.1× 204 1.0× 89 1.0× 43 1.8k
Darlene C. Deecher United States 25 636 1.0× 528 0.8× 224 0.5× 200 0.9× 99 1.1× 55 2.1k
Jean-Louis Péglion France 22 539 0.8× 596 0.9× 418 0.9× 93 0.4× 120 1.4× 38 1.4k
Patricia A. Seymour United States 20 698 1.1× 521 0.8× 444 0.9× 209 1.0× 84 1.0× 25 1.7k
Terrance H. Andree United States 23 653 1.0× 606 0.9× 454 0.9× 366 1.7× 55 0.6× 51 1.8k
Takato Hiranita United States 27 936 1.4× 1.0k 1.6× 342 0.7× 373 1.8× 56 0.6× 87 1.9k
Ottavio Gandolfi Italy 24 625 0.9× 942 1.5× 227 0.5× 157 0.7× 94 1.1× 85 1.6k
Cécile Béguin United States 19 793 1.2× 880 1.4× 240 0.5× 125 0.6× 52 0.6× 23 1.4k
Margaret S. Beer United Kingdom 24 997 1.5× 879 1.4× 481 1.0× 132 0.6× 76 0.9× 53 1.8k
Janusz J. Kulagowski United Kingdom 29 1.2k 1.8× 1.1k 1.7× 806 1.7× 160 0.8× 114 1.3× 55 2.3k

Countries citing papers authored by Boyd L. Harrison

Since Specialization
Citations

This map shows the geographic impact of Boyd L. Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boyd L. Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boyd L. Harrison more than expected).

Fields of papers citing papers by Boyd L. Harrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boyd L. Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boyd L. Harrison. The network helps show where Boyd L. Harrison may publish in the future.

Co-authorship network of co-authors of Boyd L. Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of Boyd L. Harrison. A scholar is included among the top collaborators of Boyd L. Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boyd L. Harrison. Boyd L. Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hill, Matthew D., María‐Jesús Blanco, Francesco G. Salituro, et al.. (2022). SAGE-718: A First-in-ClassN-Methyl-d-Aspartate Receptor Positive Allosteric Modulator for the Potential Treatment of Cognitive Impairment. Journal of Medicinal Chemistry. 65(13). 9063–9075. 28 indexed citations
2.
Blanco, María‐Jesús, et al.. (2017). Breakthroughs in neuroactive steroid drug discovery. Bioorganic & Medicinal Chemistry Letters. 28(2). 61–70. 40 indexed citations
3.
Dunlop, John, Stephanie W. Watts, James E. Barrett, et al.. (2011). Characterization of Vabicaserin (SCA-136), a Selective 5-Hydroxytryptamine 2C Receptor Agonist. Journal of Pharmacology and Experimental Therapeutics. 337(3). 673–680. 37 indexed citations
4.
Venkatesan, Aranapakam M., Osvaldo dos Santos, John W. Ellingboe, et al.. (2010). Novel benzofuran derivatives with dual 5-HT1A receptor and serotonin transporter affinity. Bioorganic & Medicinal Chemistry Letters. 20(3). 824–827. 26 indexed citations
5.
Shen, Zhongqi, Nicole T. Hatzenbuhler, Deborah A. Evrard, et al.. (2009). Synthesis and structure–activity relationship of novel lactam-fused chroman derivatives having dual affinity at the 5-HT1A receptor and the serotonin transporter. Bioorganic & Medicinal Chemistry Letters. 20(1). 222–227. 14 indexed citations
6.
Bernotas, Ronald C., Schuyler Antane, Simon N. Haydar, et al.. (2009). 1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-pyrrolopyridines are 5-HT6 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 19(24). 6935–6938. 8 indexed citations
7.
Bernotas, Ronald C., Schuyler Antane, Derek C. Cole, et al.. (2009). Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT6 agonists. Bioorganic & Medicinal Chemistry. 17(14). 5153–5163. 15 indexed citations
8.
Childers, Wayne E., Arlene Dietrich, Boyd L. Harrison, et al.. (2009). 3,4-Dihydropyrimido(1,2-a)indol-10(2H)-ones as potent non-peptidic inhibitors of caspase-3. Bioorganic & Medicinal Chemistry. 17(22). 7755–7768. 18 indexed citations
9.
Rosenzweig‐Lipson, Sharon, Jean Zhang, Hossein Mazandarani, et al.. (2006). Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503. Brain Research. 1073-1074. 240–251. 62 indexed citations
10.
Zhou, Dahui, Boyd L. Harrison, Terrance H. Andree, et al.. (2005). Studies toward the discovery of the next generation of antidepressants. Part 5: 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives with dual 5-HT1A receptor and serotonin transporter affinity. Bioorganic & Medicinal Chemistry Letters. 16(5). 1338–1341. 43 indexed citations
11.
Zhou, Ping, Yinfa Yan, Ronald C. Bernotas, et al.. (2005). 4-(2-Aminoethoxy)-N-(phenylsulfonyl)indoles as novel 5-HT6 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 15(5). 1393–1396. 18 indexed citations
12.
Dunlop, John, Annmarie L. Sabb, Hossein Mazandarani, et al.. (2005). WAY-163909 [(7 bR, 10 aR)-1,2,3,4,8,9,10,10 a-Octahydro-7 bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Anorectic Activity. Journal of Pharmacology and Experimental Therapeutics. 313(2). 862–869. 84 indexed citations
13.
Bernotas, Ronald C., Schuyler Antane, Deborah L. Smith, et al.. (2004). 1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-indoles as novel 5-HT6 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 14(22). 5499–5502. 39 indexed citations
14.
Sabb, Annmarie L., Robert L. Vogel, Gregory S. Welmaker, et al.. (2004). Cycloalkyl[b][1,4]benzodiazepinoindoles are agonists at the human 5-HT2C receptor. Bioorganic & Medicinal Chemistry Letters. 14(10). 2603–2607. 21 indexed citations
15.
Baron, Bruce M., Boyd L. Harrison, John H. Kehne, et al.. (1997). Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist. European Journal of Pharmacology. 323(2-3). 181–192. 40 indexed citations
16.
Kehne, John H., B M Baron, Boyd L. Harrison, et al.. (1995). MDL 100,458 and MDL 102,288: two potent and selective glycine receptor antagonists with different functional profiles. European Journal of Pharmacology. 284(1-2). 109–118. 32 indexed citations
17.
Salituro, Francesco G., Boyd L. Harrison, Bruce M. Baron, et al.. (1992). 3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the NMDA (N-methyl-D-aspartic acid) receptor associated glycine binding site. Journal of Medicinal Chemistry. 35(10). 1791–1799. 55 indexed citations
18.
Whitten, Jeffrey P., Boyd L. Harrison, Herschel J. R. Weintraub, & Ian A. McDonald. (1992). Modeling of competitive phosphono amino acid NMDA receptor antagonists. Journal of Medicinal Chemistry. 35(9). 1509–1514. 11 indexed citations
19.
Baron, Bruce M., et al.. (1991). [3H]5,7-Dichlorokynurenic acid, a novel radioligand labels NMDA receptor-associated glycine binding sites. European Journal of Pharmacology Molecular Pharmacology. 206(2). 149–154. 62 indexed citations
20.
Skoog, Mark T., James S. Nichols, Boyd L. Harrison, & Jeffrey S. Wiseman. (1988). Specificity of an HPETE peroxidase from rat PMN. Prostaglandins. 36(3). 373–384. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026